PKM1は,心臓の圧力過負荷下での心臓改造において重要な役割を果たします
Qinfeng Li1,2,3, Chao Li3, Abdallah Elnwasany3
1Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, China (Q.L., J.Lin, Y.G., M.W., G.F.).
Circulation
|June 9, 2021
まとめ
ピルーバートキナーゼ筋肉イソ酵素1 (PKM1) は,ストレス下での心臓機能の維持に不可欠です. 減少したPKM1は心臓機能不全を悪化させ,過剰発現はグルコース代謝を支えて心不全を予防する.
科学分野:
- 心臓病科
- 代謝の調節
- 分子生物学
背景:
- 心臓の過剰成長には代謝の改造があり,その主な特徴はグルコースの利用率の増加である.
- 圧力過負荷による心筋縮および心不全における心臓ピルバートキナーゼイソ酵素1 (PKM1) の正確な役割は完全に理解されていません.
研究 の 目的:
- 血糖代謝における心臓PKM1の機能と,過大圧への心臓の反応を調査する.
- PKM1が血動力学的ストレスへの心臓適応に影響を与える分子メカニズムを解明する.
主な方法:
- 心筋細胞特異的なPKM1ノックアウトと誘導性過剰表現のマウスモデルを生成した.
- 横動脈の収縮を活かして 圧力の過剰を誘導した.
- 実験室内での研究で ネズミの新生児の小室筋細胞を使用した.
- メタボロミクスと核磁気共鳴スペクトロスコーピーを用いて心臓の代謝を分析した.
主要な成果:
- PKM1の発現は,人間の心臓やマウスの心臓の機能が低下している.
- PKM1の喪失は,圧力の過剰で心臓機能障害と線維症を悪化させる.
- PKM1の過剰発現は,圧力の過剰に起因する心筋不全から心臓を保護する.
- PKM1は,強化された糖分流,ミトコンドリアの呼吸,ATPの生産に不可欠です.
- PKM1欠乏症は心筋細胞の成長とピルバート脱水素酵素複合体の活性を阻害する.
結論:
- PKM1は,血液動力学的ストレスに対する心臓の恒常反応において重要な役割を果たします.
- PKM1を標的とした治療は,心不全の管理のための治療戦略を提供することができる.
さらに関連する動画
関連する概念動画
Heart Failure II: Pathophysiology
133
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
133
Pathophysiology of Heart Failure
2.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
109
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
109
Cardiomyopathy V: Interprofessional Care
93
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
93
Cardiomyopathy II: Dilated Cardiomyopathy
111
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
111
Cardiomyopathy IV: Restrictive Cardiomyopathy
142
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
142


